Why does endoscopists and surgeons need a disposable hemoclip?
For both endoscopists and surgeons, upper gastrointestinal bleeding is a common clinical issue. About 70–80% of instances of acute haemorrhage from gastric and duodenal ulcers terminate on their own. The remaining patients are a high-risk population that has to be identified and treated right away in order to lower the high rates of morbidity and mortality. Everyone agrees that aggressive treatment is necessary for peptic ulcer patients who are bleeding or leaking blood. Patients who have ongoing or recurrent bleeding have a mortality rate of 12% to 18%. Numerous endoscopic procedures have been successfully recommended for the management of gastrointestinal bleeding, including local injection (ethanol, hypertonic saline, and epinephrine) and thermal treatment (laser, heater probe, and bicap). However, the outcomes differ according on the patients or operators.
While initial disposable hemoclip has a high success rate, 10% to 30% of patients have been found to rebleed. Hemostatic agent injections and thermal techniques might injure tissue, resulting in necrosis and even perforation. Using a metal hemoclip to provide mechanical hemostasis to a bleeding vessel is an attractive substitute for the methods that are already in use. Hayashi et al. initially presented it in 1975. But the initial encounter was demoralising due to its intricacy and poor memory rate. With a permanent hemostatic rate of 84.3%, Hachisu introduced a modified hemoclip for upper gastrointestinal haemorrhage in 1988. Recently, a rotatable clip-device with enhanced g rasping capabilities was created, which can speed up and simplify the process. Thus, we prospectively assessed the methitic clip's function in the hemostatic effect on bleeding peptic ulcers using this newly enhanced model.
How are disposable hemoclips operated?
Cutting makes it possible to constrict bleeding veins and accomplish mechanical sealing without changing the size or depth of the ulcer. After three weeks, clips naturally come loose and travel through the digestive system without incident. It was stated that there was not much injury to the nearby tissue. Follow-up endoscopy in this trial revealed no evidence of tissue damage or ulcer healing impairment due to clips. Our results verify that the clip location did not cause any evident difficulties. Injection therapy as well as thermal probes are commonly employed. They have a 75% to 95% hemostatic rate.
What do we know about disposable hemoclip
Endoscopic disposable hemoclip treatment for bleeding peptic ulcer is an effective and safe modality. It has a high initial hemostatic rate (95%) and a low rebleeding rate (8%). Ultimate hemostasis reached 93% in our study with no obvious complications. With the development of newly developed clips and clip application devices, the endoscopic hemoclip treatment has become easier and much more efficient. Endoscopic hemoclip treatment deserves further comparative studies with other hemostatic methods.
